Business Wire

Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug ...
Monthly Prescribing Reference

FDA Authorizes Use of Oral Antiviral Molnupiravir for Mild to Moderate COVID-19

Credit: Merck. The EUA was supported by data from the phase 3 MOVe-OUT trial, which compared the efficacy and safety of molnupiravir to placebo in 775 nonhospitalized adults with symptom onset within ...
Healio

FDA issues EUA for Merck’s COVID-19 antiviral molnupiravir

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA has issued an emergency use ...
GEN

Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase III Data

Merck & Co., said today it will pursue FDA emergency use authorization (EUA) “as soon as possible” for molnupiravir, the COVID-19 oral antiviral candidate it is developing with Ridgeback ...
BioWorld

Wording of potential molnupiravir EUA key to scope of use, risk

One of the biggest concerns at the Nov. 30 meeting of the FDA’s Antimicrobial Drugs Advisory Committee is that, if Merck & Co. Inc.-Ridgeback Biotherapeutics Inc.’s antiviral drug, molnupiravir, is ...
New Atlas

First COVID-19 pill passes human trials, looks to FDA approval

Pharmaceutical company Merck has revealed the first data from its large Phase 3 trial of an oral antiviral treatment for COVID-19. The interim results show the treatment reduces a person’s risk of ...
Business Insider

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

SILVER SPRING, Md., Dec. 23, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck's molnupiravir for the treatment of ...
Acsh.org

Should Merck’s COVID Pill Be Granted Emergency Use Authorization?

Emergency Use Authorization (EUA) from the FDA is the exception, not the rule. Except for COVID therapies. Three vaccines and one drug have EUA in the US. Merck is now seeking EUA for its antiviral ...
Healio

Merck submits EUA request for oral antiviral molnupiravir as COVID-19 treatment

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Merck and Ridgeback Biotherapeutics have ...
Business Wire

Merck and Ridgeback Announce Submission of Emergency Use Authorization Application to the U.S. FDA for Molnupiravir, an Investigational Oral Antiviral Medicine, for the ...

KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that Merck has submitted an Emergency Use ...
Indiatimes

Cipla gets EUA from DCGI to market Molnupiravir for COVID-19 treatment

New Delhi, Dec 28 (PTI) Drug major Cipla on Tuesday said it has received emergency use authorisation (EUA) permission from the Drug Controller General of India (DCGI) to launch antiviral drug ...
CSR Wire

Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

Submitted by Merck & Co., Inc. KENILWORTH, N.J. & MIAMI, December 28, 2021, /CSRwire/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced ...